TRACY DONOVAN: Open Payments
NPI 1174025662 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $374 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 4 | $60 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Incyte Corporation | 1 | $29 |
| Celgene Corporation | 1 | $27 |
| Astellas Pharma US Inc | 1 | $23 |
| Tempus AI, Inc | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $18 |
Products named: CALQUENCE, Enhertu, SCEMBLIX, MONJUVI, REBLOZYL, Vyloy, XT CDX, Trodelvy.
Industry payments across OH — which companies pay providers there.
